Loading...
Header Logo
Keywords
Last Name
Institution

STEPHEN HAHN

TitleProfessor
InstitutionMD Anderson
DepartmentRadiation Oncology
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Baumann BC, Bernstein KA, DeLaney TF, Simone CB, Kolker JD, Choy E, Levin WP, Weber KL, Muniappan A, Berman AT, Staddon A, Hartner L, Van Tine B, Hirbe A, Glatstein E, Hahn SM, Nagda SN, Chen YL. Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicity. J Surg Oncol. 2020 Jun 25. PMID: 32588468.
      View in: PubMed
    2. Mesko S, Ning MS, Lakomy D, Verma V, Chang JY, O'Reilly M, Jeter MD, Gandhi SJ, Lin SH, Nguyen QN, Liao Z, Welsh J, Chen AB, Hahn S, Gomez DR. Thoracic Radiation Oncology Clinical Trial Accrual and Reasons for Nonenrollment: Results of a Large, Prospective, Multiyear Analysis. Int J Radiat Oncol Biol Phys. 2020 Aug 01; 107(5):897-908. PMID: 32360653.
      View in: PubMed
    3. Cramer G, Lewis R, Gymarty A, Hagan S, Mickler M, Evans S, Punekar SR, Shuman L, Simone CB, Hahn SM, Busch TM, Fraker D, Cengel KA. Preclinical Evaluation of Cetuximab and Benzoporphyrin Derivative-Mediated Intraperitoneal Photodynamic Therapy in a Canine Model. Photochem Photobiol. 2020 05; 96(3):684-691. PMID: 32119123.
      View in: PubMed
    4. Palma G, Monti S, Conson M, Xu T, Hahn S, Durante M, Mohan R, Liao Z, Cella L. NTCP Models for Severe Radiation Induced Dermatitis After IMRT or Proton Therapy for Thoracic Cancer Patients. Front Oncol. 2020; 10:344. PMID: 32257950.
      View in: PubMed
    5. Coleman CN, Mitchell JB, Hahn SM, McKenna WG. Eli J. Glatstein: Inspiring and Provoking Critical Thinking. Radiat Res. 2020 04; 193(4):318-321. PMID: 31999506.
      View in: PubMed
    6. Frick MA, Feigenberg SJ, Jean-Baptiste SR, Aguarin LA, Mendes A, Chinniah C, Swisher-McClure S, Berman A, Levin W, Cengel KA, Hahn SM, Dorsey JF, Simone CB, Kao GD. Circulating Tumor Cells Are Associated with Recurrent Disease in Patients with Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy. Clin Cancer Res. 2020 May 15; 26(10):2372-2380. PMID: 31969332.
      View in: PubMed
    7. Welsh JW, Tang C, de Groot P, Naing A, Hess KR, Heymach JV, Papadimitrakopoulou VA, Cushman TR, Subbiah V, Chang JY, Simon GR, Ramapriyan R, Barsoumian HB, Menon H, Cortez MA, Massarelli E, Nguyen Q, Sharma P, Allison JP, Diab A, Verma V, Raju U, Shaaban SG, Dadu R, Cabanillas ME, Wang K, Anderson C, Gomez DR, Hahn S, Komaki R, Hong DS. Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses. Cancer Immunol Res. 2019 12; 7(12):1903-1909. PMID: 31658994.
      View in: PubMed
    8. Moreno AC, Fellman B, Hobbs BP, Liao Z, Gomez DR, Chen A, Hahn SM, Chang JY, Lin SH. Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients With Early-Stage NSCLC. J Thorac Oncol. 2020 01; 15(1):101-109. PMID: 31479748.
      View in: PubMed
    9. Rengan R, Mick R, Pryma DA, Lin LL, Christodouleas J, Plastaras JP, Simone CB, Gupta AK, Evans TL, Stevenson JP, Langer CJ, Kucharczuk J, Friedberg J, Lam S, Patsch D, Hahn SM, Maity A. Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir With Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer: A Phase 1/2 Trial. JAMA Oncol. 2019 Aug 22. PMID: 31436839.
      View in: PubMed
    10. Nguyen QN, Chun SG, Chow E, Komaki R, Liao Z, Zacharia R, Szeto BK, Welsh JW, Hahn SM, Fuller CD, Moon BS, Bird JE, Satcher R, Lin PP, Jeter M, O'Reilly MS, Lewis VO. Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 Trial. JAMA Oncol. 2019 Jun 01; 5(6):872-878. PMID: 31021390.
      View in: PubMed
    11. Chinniah C, Aguarin L, Cheng P, Decesaris C, Cutillo A, Berman AT, Frick M, Doucette A, Cengel KA, Levin W, Hahn S, Dorsey JF, Simone CB, Kao GD. Early Detection of Recurrence in Patients With Locally Advanced Non-Small-Cell Lung Cancer via Circulating Tumor Cell Analysis. Clin Lung Cancer. 2019 09; 20(5):384-390.e2. PMID: 31221522.
      View in: PubMed
    12. Palma G, Monti S, Xu T, Scifoni E, Yang P, Hahn SM, Durante M, Mohan R, Liao Z, Cella L. Spatial Dose Patterns Associated With Radiation Pneumonitis in a Randomized Trial Comparing Intensity-Modulated Photon Therapy With Passive Scattering Proton Therapy for Locally Advanced Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2019 08 01; 104(5):1124-1132. PMID: 30822531.
      View in: PubMed
    13. Menon H, Ramapriyan R, Cushman TR, Verma V, Kim HH, Schoenhals JE, Atalar C, Selek U, Chun SG, Chang JY, Barsoumian HB, Nguyen QN, Altan M, Cortez MA, Hahn SM, Welsh JW. Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment. Front Immunol. 2019; 10:193. PMID: 30828330.
      View in: PubMed
    14. Beeler WH, Griffith KA, Jones RD, Chapman CH, Holliday EB, Lalani N, Wilson E, Bonner JA, Formenti SC, Hahn SM, Kalnicki S, Liu FF, Movsas B, Thomas CR, Jagsi R. Gender, Professional Experiences, and Personal Characteristics of Academic Radiation Oncology Chairs: Data to Inform the Pipeline for the 21st Century. Int J Radiat Oncol Biol Phys. 2019 08 01; 104(5):979-986. PMID: 30684662.
      View in: PubMed
    15. Wallner PE, McGeagh AM, Gerdeman AM, Wilson LD, Shrieve DC, Alektiar KM, Hahn SM, Kachnic LA, Jackson VP. Snapshot of a Specialty: Results of the ABR 2016 Radiation Oncology Clinical Practice Analysis. J Am Coll Radiol. 2019 Apr; 16(4 Pt A):513-517. PMID: 30584037.
      View in: PubMed
    16. Lin C, Verma V, Ly QP, Lazenby A, Sasson A, Schwarz JK, Meza JL, Are C, Li S, Wang S, Hahn SM, Grem JL. Phase I trial of concurrent stereotactic body radiotherapy and nelfinavir for locally advanced borderline or unresectable pancreatic adenocarcinoma. Radiother Oncol. 2019 03; 132:55-62. PMID: 30825970.
      View in: PubMed
    17. Ahmad SS, Crittenden MR, Tran PT, Kluetz PG, Blumenthal GM, Bulbeck H, Baird RD, Williams KJ, Illidge T, Hahn SM, Lawrence TS, Spears PA, Walker AJ, Sharma RA. Clinical Development of Novel Drug-Radiotherapy Combinations. Clin Cancer Res. 2019 03 01; 25(5):1455-1461. PMID: 30498095.
      View in: PubMed
    18. Wallner PE, Hahn SM, Zietman AL. Whither Thou Goest, I Will Go. Int J Radiat Oncol Biol Phys. 2018 11 15; 102(4):677-679. PMID: 30353875.
      View in: PubMed
    19. Maity A, Mick R, Huang AC, George SM, Farwell MD, Lukens JN, Berman AT, Mitchell TC, Bauml J, Schuchter LM, O'Hara M, Lin LL, Demichele A, Christodouleas JP, Haas NB, Patsch DM, Hahn SM, Minn AJ, Wherry EJ, Vonderheide RH. A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours. Br J Cancer. 2018 11; 119(10):1200-1207. PMID: 30318516.
      View in: PubMed
    20. Schonewolf CA, Heskel M, Doucette A, Singhal S, Frick MA, Xanthopoulos EP, Corradetti MN, Friedberg JS, Pechet TT, Christodouleas JP, Levin W, Berman A, Cengel KA, Verma V, Hahn SM, Kucharczuk JC, Rengan R, Simone CB. Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non-small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location. Clin Lung Cancer. 2019 01; 20(1):e63-e71. PMID: 30337269.
      View in: PubMed
    21. Brooks ED, Sun B, Feng L, Verma V, Zhao L, Gomez DR, Liao Z, Jeter M, O'Reilly M, Welsh JW, Nguyen QN, Erasmus JJ, Eapen G, Ahrar K, Antonoff MB, Hahn SM, Heymach JV, Rice DC, Chang JY. Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer. JAMA Netw Open. 2018 08 03; 1(4):e181390. PMID: 30646121.
      View in: PubMed
    22. Pezzi TA, Schwartz DL, Mohamed ASR, Welsh JW, Komaki RU, Hahn SM, Sepesi B, Pezzi CM, Fuller CD, Chun SG. Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer. JAMA Oncol. 2018 08 01; 4(8):e174504. PMID: 29302695.
      View in: PubMed
    23. Frick MA, Kao GD, Aguarin L, Chinniah C, Swisher-McClure S, Berman AT, Levin WP, Cengel KA, DeCesaris C, Hahn SM, Dorsey JF, Simone CB. Circulating Tumor Cell Assessment in Presumed Early Stage Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy: A Prospective Pilot Study. Int J Radiat Oncol Biol Phys. 2018 11 01; 102(3):536-542. PMID: 30244877.
      View in: PubMed
    24. Yang J, Xu T, Gomez DR, Yuan X, Nguyen QN, Jeter M, Song Y, Komaki R, Hu Y, Hahn SM, Liao Z. Nomograms incorporating genetic variants in BMP/Smad4/Hamp pathway to predict disease outcomes after definitive radiotherapy for non-small cell lung cancer. Cancer Med. 2018 06; 7(6):2247-2255. PMID: 29745043.
      View in: PubMed
    25. Topkan E, Selek U, Ozdemir Y, Yildirim BA, Guler OC, Mertsoylu H, Hahn SM. Chemoradiotherapy-induced hemoglobin nadir values and survival in patients with stage III non-small cell lung cancer. Lung Cancer. 2018 07; 121:30-36. PMID: 29858023.
      View in: PubMed
    26. Mujoo K, Hunt CR, Pandita RK, Ferrari M, Krishnan S, Cooke JP, Hahn S, Pandita TK. Harnessing and Optimizing the Interplay between Immunotherapy and Radiotherapy to Improve Survival Outcomes. Mol Cancer Res. 2018 08; 16(8):1209-1214. PMID: 29592896.
      View in: PubMed
    27. Huang Y, Kim BYS, Chan CK, Hahn SM, Weissman IL, Jiang W. Improving immune-vascular crosstalk for cancer immunotherapy. Nat Rev Immunol. 2018 03; 18(3):195-203. PMID: 29332937.
      View in: PubMed
    28. Jones RD, Chapman CH, Holliday EB, Lalani N, Wilson E, Bonner JA, Movsas B, Kalnicki S, Formenti SC, Thomas CR, Hahn SM, Liu FF, Jagsi R. Qualitative Assessment of Academic Radiation Oncology Department Chairs' Insights on Diversity, Equity, and Inclusion: Progress, Challenges, and Future Aspirations. Int J Radiat Oncol Biol Phys. 2018 05 01; 101(1):30-45. PMID: 29477292.
      View in: PubMed
    29. Liao Z, Lee JJ, Komaki R, Gomez DR, O'Reilly MS, Fossella FV, Blumenschein GR, Heymach JV, Vaporciyan AA, Swisher SG, Allen PK, Choi NC, DeLaney TF, Hahn SM, Cox JD, Lu CS, Mohan R. Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer. J Clin Oncol. 2018 06 20; 36(18):1813-1822. PMID: 29293386.
      View in: PubMed
    30. Pezzi TA, Tang C, Swanick CW, Fang P, Hess K, Xu T, Hahn SM, Chang JY, Liao Z, Gomez D. Patterns and correlates of treatment failure in relation to isodose distribution in non-small cell lung cancer: An analysis of 1522 patients in the modern era. Radiother Oncol. 2017 11; 125(2):325-330. PMID: 29054376.
      View in: PubMed
    31. Chun SG, Solberg TD, Grosshans DR, Nguyen QN, Simone CB, Mohan R, Liao Z, Hahn SM, Herman JM, Frank SJ. The Potential of Heavy-Ion Therapy to Improve Outcomes for Locally Advanced Non-Small Cell Lung Cancer. Front Oncol. 2017; 7:201. PMID: 28929085.
      View in: PubMed
    32. Holliday EB, Bonner JA, Formenti SC, Hahn SM, Kalnicki S, Liu FF, Movsas B, Fuller CD, Thomas CR. Emotional Intelligence and Burnout in Academic Radiation Oncology Chairs. J Healthc Manag. 2017 Sep/Oct; 62(5):302-313. PMID: 28885530.
      View in: PubMed
    33. Chang JY, Verma V, Li M, Zhang W, Komaki R, Lu C, Allen PK, Liao Z, Welsh J, Lin SH, Gomez D, Jeter M, O'Reilly M, Zhu RX, Zhang X, Li H, Mohan R, Heymach JV, Vaporciyan AA, Hahn S, Cox JD. Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study. JAMA Oncol. 2017 08 10; 3(8):e172032. PMID: 28727865.
      View in: PubMed
    34. Ho JC, Nguyen QN, Li H, Allen PK, Zhang X, Liao Z, Zhu XR, Gomez D, Lin SH, Gillin M, Komaki R, Hahn S, Chang JY. Reirradiation of thoracic cancers with intensity modulated proton therapy. Pract Radiat Oncol. 2018 Jan - Feb; 8(1):58-65. PMID: 28867546.
      View in: PubMed
    35. Guttmann DM, Frick MA, Carmona R, Deville C, Levin WP, Berman AT, Chinniah C, Hahn SM, Plastaras JP, Simone CB. A prospective study of proton reirradiation for recurrent and secondary soft tissue sarcoma. Radiother Oncol. 2017 08; 124(2):271-276. PMID: 28697854.
      View in: PubMed
    36. Verma V, Simone CB, Krishnan S, Lin SH, Yang J, Hahn SM. The Rise of Radiomics and Implications for Oncologic Management. J Natl Cancer Inst. 2017 07 01; 109(7). PMID: 28423406.
      View in: PubMed
    37. Yang J, Xu T, Gomez DR, Yuan X, Nguyen QN, Jeter M, Song Y, Hahn S, Liao Z. Polymorphisms in BMP2/BMP4, with estimates of mean lung dose, predict radiation pneumonitis among patients receiving definitive radiotherapy for non-small cell lung cancer. Oncotarget. 2017 Jun 27; 8(26):43080-43090. PMID: 28574846.
      View in: PubMed
    38. Sun B, Brooks ED, Komaki RU, Liao Z, Jeter MD, McAleer MF, Allen PK, Balter PA, Welsh JD, O'Reilly MS, Gomez D, Hahn SM, Roth JA, Mehran RJ, Heymach JV, Chang JY. 7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial. Cancer. 2017 Aug 15; 123(16):3031-3039. PMID: 28346656.
      View in: PubMed
    39. Sun B, Brooks ED, Komaki R, Liao Z, Jeter M, McAleer M, Balter PA, Welsh JD, O'Reilly M, Gomez D, Hahn SM, Sepesi B, Rice DC, Heymach JV, Chang JY. Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non-Small Cell Lung Cancer: A Phase II Clinical Trial. J Thorac Oncol. 2017 06; 12(6):983-992. PMID: 28259750.
      View in: PubMed
    40. Yang J, Xu T, Gomez DR, Jeter M, Levy LB, Song Y, Hahn S, Liao Z, Yuan X. The Pulmonary Fibrosis Associated MUC5B Promoter Polymorphism Is Prognostic of the Overall Survival in Patients with Non-Small Cell Lung Cancer (NSCLC) Receiving Definitive Radiotherapy. Transl Oncol. 2017 Apr; 10(2):197-202. PMID: 28189065.
      View in: PubMed
    41. Pezzi TA, Mohamed AS, Fuller CD, Blanchard P, Pezzi C, Sepesi B, Hahn SM, Gomez DR, Chun SG. Radiation Therapy is Independently Associated with Worse Survival After R0-Resection for Stage I-II Non-small Cell Lung Cancer: An Analysis of the National Cancer Data Base. Ann Surg Oncol. 2017 May; 24(5):1419-1427. PMID: 28154950.
      View in: PubMed
    42. Chang JY, Zhang W, Komaki R, Choi NC, Chan S, Gomez D, O'Reilly M, Jeter M, Gillin M, Zhu X, Zhang X, Mohan R, Swisher S, Hahn S, Cox JD. Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer. Radiother Oncol. 2017 02; 122(2):274-280. PMID: 28139305.
      View in: PubMed
    43. DeLaney TF, Chen YL, Baldini EH, Wang D, Adams J, Hickey SB, Yeap BY, Hahn SM, De Amorim Bernstein K, Nielsen GP, Choy E, Mullen JT, Yoon SS. Phase 1 trial of preoperative image guided intensity modulated proton radiation therapy with simultaneously integrated boost to the high risk margin for retroperitoneal sarcomas. Adv Radiat Oncol. 2017 Jan-Mar; 2(1):85-93. PMID: 28740917.
      View in: PubMed
    44. Brooks ED, Sun B, Zhao L, Komaki R, Liao Z, Jeter M, Welsh JW, O'Reilly MS, Gomez DR, Hahn SM, Heymach JV, Rice DC, Chang JY. Stereotactic Ablative Radiation Therapy is Highly Safe and Effective for Elderly Patients With Early-stage Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2017 07 15; 98(4):900-907. PMID: 28258887.
      View in: PubMed
    45. Coelho RC, Da Silva FML, Do Carmo IML, Bonaccorsi BV, Hahn SM, Faroni LD. Is there a role for salvage radiotherapy in locally advanced breast cancer refractory to neoadjuvant chemotherapy? Breast. 2017 Feb; 31:192-196. PMID: 27889595.
      View in: PubMed
    46. Wang X, Schoenhals JE, Li A, Valdecanas DR, Ye H, Zang F, Tang C, Tang M, Liu CG, Liu X, Krishnan S, Allison JP, Sharma P, Hwu P, Komaki R, Overwijk WW, Gomez DR, Chang JY, Hahn SM, Cortez MA, Welsh JW. Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy. Cancer Res. 2017 02 15; 77(4):839-850. PMID: 27821490.
      View in: PubMed
    47. Chao HH, Berman AT, Simone CB, Ciunci C, Gabriel P, Lin H, Both S, Langer C, Lelionis K, Rengan R, Hahn SM, Prabhu K, Fagundes M, Hartsell W, Mick R, Plastaras JP. Multi-Institutional Prospective Study of Reirradiation with Proton Beam Radiotherapy for Locoregionally Recurrent Non-Small Cell Lung Cancer. J Thorac Oncol. 2017 02; 12(2):281-292. PMID: 27826034.
      View in: PubMed
    48. Friedberg JS, Simone CB, Culligan MJ, Barsky AR, Doucette A, McNulty S, Hahn SM, Alley E, Sterman DH, Glatstein E, Cengel KA. Extended Pleurectomy-Decortication-Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years. Ann Thorac Surg. 2017 Mar; 103(3):912-919. PMID: 27825687.
      View in: PubMed
    49. Jiang W, Chan CK, Weissman IL, Kim BYS, Hahn SM. Immune Priming of the Tumor Microenvironment by Radiation. Trends Cancer. 2016 11; 2(11):638-645. PMID: 28741502.
      View in: PubMed
    50. Zeng C, Plastaras JP, James P, Tochner ZA, Hill-Kayser CE, Hahn SM, Both S. Proton pencil beam scanning for mediastinal lymphoma: treatment planning and robustness assessment. Acta Oncol. 2016 Sep - Oct; 55(9-10):1132-1138. PMID: 27332881.
      View in: PubMed
    51. Baumann BC, Nagda SN, Kolker JD, Levin WP, Weber KL, Berman AT, Staddon A, Hartner L, Hahn SM, Glatstein E, Simone CB. Efficacy and safety of stereotactic body radiation therapy for the treatment of pulmonary metastases from sarcoma: A potential alternative to resection. J Surg Oncol. 2016 Jul; 114(1):65-9. PMID: 27111504.
      View in: PubMed
    52. Woodhouse KD, Volz E, Maity A, Gabriel PE, Solberg TD, Bergendahl HW, Hahn SM. Journey Toward High Reliability: A Comprehensive Safety Program to Improve Quality of Care and Safety Culture in a Large, Multisite Radiation Oncology Department. J Oncol Pract. 2016 05; 12(5):e603-12. PMID: 27026647.
      View in: PubMed
    53. Thaker NG, Agarwal A, Palmer M, Hontiveros R, Hahn SM, Minsky BD, Walters R, Bingham J, Feeley TW, Buchholz TA, Frank SJ. Variations in Proton Therapy Coverage in the State of Texas: Defining Medical Necessity for a Safe and Effective Treatment. Int J Part Ther. 2016 Mar; 2(4):499-508. PMID: 31772962.
      View in: PubMed
    54. Gabriel PE, Woodhouse KD, Lin A, Finlay JC, Young RB, Volz E, Hahn SM, Metz JM, Maity A. An automated electronic system for managing radiation treatment plan peer review reduces missed reviews at a large, high-volume academic center. Pract Radiat Oncol. 2016 Nov - Dec; 6(6):e307-e314. PMID: 27155763.
      View in: PubMed
    55. Pan HY, Haffty BG, Falit BP, Buchholz TA, Wilson LD, Hahn SM, Smith BD. Supply and Demand for Radiation Oncology in the United States: Updated Projections for 2015 to 2025. Int J Radiat Oncol Biol Phys. 2016 11 01; 96(3):493-500. PMID: 27209499.
      View in: PubMed
    56. Schoenhals JE, Seyedin SN, Tang C, Cortez MA, Niknam S, Tsouko E, Chang JY, Hahn SM, Welsh JW. Preclinical Rationale and Clinical Considerations for Radiotherapy Plus Immunotherapy: Going Beyond Local Control. Cancer J. 2016 Mar-Apr; 22(2):130-7. PMID: 27111909.
      View in: PubMed
    57. Thaker NG, Sturdevant L, Jhingran A, Das P, Delclos ME, Gunn GB, McAleer MF, Tereffe W, Choi SL, Frank SJ, Simeone WJ, Martinez W, Hahn SM, Famiglietti R, Kuban DA. Assessing the Quality of a Radiation Oncology Case-Based, Peer-Review Program in an Integrated Academic and Community Cancer Center Network. J Oncol Pract. 2016 Apr; 12(4):e476-86. PMID: 26931402.
      View in: PubMed
    58. Gameiro SR, Malamas AS, Bernstein MB, Tsang KY, Vassantachart A, Sahoo N, Tailor R, Pidikiti R, Guha CP, Hahn SM, Krishnan S, Hodge JW. Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated Killing. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):120-130. PMID: 27084634.
      View in: PubMed
    59. Wallner PE, Shrieve DC, Kachnic LA, Wilson LD, Hahn S, Alektiar KM, Laszakovits D, Guiberteau MJ. American Board of Radiology Maintenance of Certification Program: Evolution to Better Serve Stakeholders. Int J Radiat Oncol Biol Phys. 2016 Jan 01; 94(1):16-18. PMID: 26700699.
      View in: PubMed
    60. Woodhouse KD, Volz E, Bellerive M, Bergendahl HW, Gabriel PE, Maity A, Hahn SM, Vapiwala N. The implementation and assessment of a quality and safety culture education program in a large radiation oncology department. Pract Radiat Oncol. 2016 Jul-Aug; 6(4):e127-e134. PMID: 26850651.
      View in: PubMed
    61. Grover S, Raesima M, Bvochora-Nsingo M, Chiyapo SP, Balang D, Tapela N, Balogun O, Kayembe MK, Russell AH, Monare B, Tanyala S, Bhat J, Thipe K, Nchunga M, Mayisela S, Kizito B, Ho-Foster A, Gaolebale BE, Gaolebale PA, Efstathiou JA, Dryden-Peterson S, Zetola N, Hahn SM, Robertson ES, Lin LL, Morroni C, Ramogola-Masire D. Cervical Cancer in Botswana: Current State and Future Steps for Screening and Treatment Programs. Front Oncol. 2015; 5:239. PMID: 26579491.
      View in: PubMed
    62. Olson AC, Coleman CN, Hahn SM, DeWeese TL, Shulman LN, Chabner BA, Chao N, Martei YM, Mundt AJ, Grover S. A Roadmap for a New Academic Pathway for Global Radiation Oncology. Int J Radiat Oncol Biol Phys. 2015 Nov 01; 93(3):493-6. PMID: 26460990.
      View in: PubMed
    63. Zindler JD, Thomas CR, Hahn SM, Hoffmann AL, Troost EG, Lambin P. Increasing the Therapeutic Ratio of Stereotactic Ablative Radiotherapy by Individualized Isotoxic Dose Prescription. J Natl Cancer Inst. 2016 Feb; 108(2). PMID: 26476075.
      View in: PubMed
    64. Bekelman JE, Mitra N, Handorf EA, Uzzo RG, Hahn SM, Polsky D, Armstrong K. Reply to G. Gandaglia et al and K. Lu. J Clin Oncol. 2015 Sep 01; 33(25):2833. PMID: 26215947.
      View in: PubMed
    65. Hill-Kayser CE, Gabriel P, Volz E, Lustig RA, Tochner Z, Hahn SM, Maity A. Factors associated with event reporting in the pediatric radiation oncology population using an electronic incident reporting system. Pract Radiat Oncol. 2015 Sep-Oct; 5(5):e417-e422. PMID: 26215584.
      View in: PubMed
    66. Chetty IJ, Martel MK, Jaffray DA, Benedict SH, Hahn SM, Berbeco R, Deye J, Jeraj R, Kavanagh B, Krishnan S, Lee N, Low DA, Mankoff D, Marks LB, Ollendorf D, Paganetti H, Ross B, Siochi RA, Timmerman RD, Wong JW. Technology for Innovation in Radiation Oncology. Int J Radiat Oncol Biol Phys. 2015 Nov 01; 93(3):485-92. PMID: 26460989.
      View in: PubMed
    67. Thomas CR, Bonner JA, Hahn SM, Lawrence TS, Liu FF, Formenti SC. Society of Chairs of Academic Radiation Oncology Programs-Endorsed Radiation Oncology Department Review Process. Int J Radiat Oncol Biol Phys. 2015 Jul 01; 92(3):536-9. PMID: 26068488.
      View in: PubMed
    68. Grover S, Balogun OD, Yamoah K, Groen R, Shah M, Rodin D, Martei Y, Olson AC, Slone JS, Shulman LN, Coleman CN, Hahn SM. Corrigendum: "Training Global Oncologists: Addressing the Global Cancer Control Problem". Front Oncol. 2015; 5:133. PMID: 26114095.
      View in: PubMed
    69. Formenti SC, Bonner JF, Hahn SM, Lawrence TS, Liu FF, Thomas CR. Raising the next generation of physician-scientists: the chairs' perspective. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):211-3. PMID: 25968820.
      View in: PubMed
    70. Wallner PE, Steinberg ML, McBride WH, Hahn SM, Zietman AL. A fork in the road: choosing the path of relevance. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):214-6. PMID: 25968821.
      View in: PubMed
    71. Swisher-McClure S, Hahn SM, Bekelman J. Proton beam therapy: the next disruptive innovation in healthcare? Postgrad Med J. 2015 May; 91(1075):241-3. PMID: 25976493.
      View in: PubMed
    72. Lukens JN, Lin A, Hahn SM. Proton therapy for head and neck cancer. Curr Opin Oncol. 2015 May; 27(3):165-71. PMID: 25811343.
      View in: PubMed
    73. Grover S, Balogun OD, Yamoah K, Groen R, Shah M, Rodin D, Olson AC, Slone JS, Shulman LN, Coleman CN, Hahn SM. Training global oncologists: addressing the global cancer control problem. Front Oncol. 2015; 5:80. PMID: 25905040.
      View in: PubMed
    74. Gabriel PE, Volz E, Bergendahl HW, Burke SV, Solberg TD, Maity A, Hahn SM. Incident learning in pursuit of high reliability: implementing a comprehensive, low-threshold reporting program in a large, multisite radiation oncology department. Jt Comm J Qual Patient Saf. 2015 Apr; 41(4):160-8. PMID: 25977200.
      View in: PubMed
    75. Xu MJ, Cooke M, Steinmetz D, Karakousis G, Saxena D, Bartlett E, Xu X, Hahn SM, Dorsey JF, Kao GD. A novel approach for the detection and genetic analysis of live melanoma circulating tumor cells. PLoS One. 2015; 10(3):e0123376. PMID: 25807549.
      View in: PubMed
    76. Gandhi SJ, Minn AJ, Vonderheide RH, Wherry EJ, Hahn SM, Maity A. Awakening the immune system with radiation: Optimal dose and fractionation. Cancer Lett. 2015 Nov 28; 368(2):185-90. PMID: 25799953.
      View in: PubMed
    77. Zeng C, Plastaras JP, Tochner ZA, White BM, Hill-Kayser CE, Hahn SM, Both S. Proton pencil beam scanning for mediastinal lymphoma: the impact of interplay between target motion and beam scanning. Phys Med Biol. 2015 Apr 07; 60(7):3013-29. PMID: 25789418.
      View in: PubMed
    78. Twyman-Saint Victor C, Rech AJ, Maity A, Rengan R, Pauken KE, Stelekati E, Benci JL, Xu B, Dada H, Odorizzi PM, Herati RS, Mansfield KD, Patsch D, Amaravadi RK, Schuchter LM, Ishwaran H, Mick R, Pryma DA, Xu X, Feldman MD, Gangadhar TC, Hahn SM, Wherry EJ, Vonderheide RH, Minn AJ. Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer. Nature. 2015 Apr 16; 520(7547):373-7. PMID: 25754329.
      View in: PubMed
    79. Fang P, Mick R, Deville C, Both S, Bekelman JE, Christodouleas JP, Guzzo TJ, Tochner Z, Hahn SM, Vapiwala N. A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer. Cancer. 2015 Apr 01; 121(7):1118-27. PMID: 25423899.
      View in: PubMed
    80. Coleman CN, Formenti SC, Williams TR, Petereit DG, Soo KC, Wong J, Chao N, Shulman LN, Grover S, Magrath I, Hahn S, Liu FF, DeWeese T, Khleif SN, Steinberg M, Roth L, Pistenmaa DA, Love RR, Mohiuddin M, Vikram B. The international cancer expert corps: a unique approach for sustainable cancer care in low and lower-middle income countries. Front Oncol. 2014; 4:333. PMID: 25478326.
      View in: PubMed
    81. Welsh JW, Seyedin SN, Cortez MA, Maity A, Hahn SM. Galectin-1 and immune suppression during radiotherapy. Clin Cancer Res. 2014 Dec 15; 20(24):6230-2. PMID: 25348514.
      View in: PubMed
    82. Wilson LD, Hahn SM, Haffty BG, Dosoretz AP. Academic radiation oncology faculty recruitment: a chair's perspective. Int J Radiat Oncol Biol Phys. 2014 Oct 01; 90(2):463-5. PMID: 25304798.
      View in: PubMed
    83. Dorsey JF, Kao GD, MacArthur KM, Ju M, Steinmetz D, Wileyto EP, Simone CB, Hahn SM. Tracking viable circulating tumor cells (CTCs) in the peripheral blood of non-small cell lung cancer (NSCLC) patients undergoing definitive radiation therapy: pilot study results. Cancer. 2015 Jan 01; 121(1):139-49. PMID: 25241991.
      View in: PubMed
    84. Finlay JC, Zhu TC, Dimofte A, Stripp D, Malkowicz SB, Whittington R, Miles J, Glatstein E, Hahn SM. In vivo determination of the absorption and scattering spectra of the human prostate during photodynamic therapy. Proc SPIE Int Soc Opt Eng. 2014 Jun 14; 5315:132-142. PMID: 26146442.
      View in: PubMed
    85. Bekelman JE, Asch DA, Tochner Z, Friedberg J, Vaughn DJ, Rash E, Raksowski K, Hahn SM. Principles and reality of proton therapy treatment allocation. Int J Radiat Oncol Biol Phys. 2014 Jul 01; 89(3):499-508. PMID: 24798985.
      View in: PubMed
    86. Bekelman JE, Hahn SM. Reference pricing with evidence development: a way forward for proton therapy. J Clin Oncol. 2014 May 20; 32(15):1540-2. PMID: 24752049.
      View in: PubMed
    87. Ju M, Kao GD, Steinmetz D, Chandrasekaran S, Keefe SM, Guzzo TJ, Christodouleas JP, Hahn SM, Dorsey JF. Application of a telomerase-based circulating tumor cell (CTC) assay in bladder cancer patients receiving postoperative radiation therapy: a case study. Cancer Biol Ther. 2014 Jun 01; 15(6):683-7. PMID: 24618718.
      View in: PubMed
    88. Macarthur KM, Kao GD, Chandrasekaran S, Alonso-Basanta M, Chapman C, Lustig RA, Wileyto EP, Hahn SM, Dorsey JF. Detection of brain tumor cells in the peripheral blood by a telomerase promoter-based assay. Cancer Res. 2014 Apr 15; 74(8):2152-9. PMID: 24525740.
      View in: PubMed
    89. Joh DY, Kao GD, Murty S, Stangl M, Sun L, Al Zaki A, Xu X, Hahn SM, Tsourkas A, Dorsey JF. Theranostic gold nanoparticles modified for durable systemic circulation effectively and safely enhance the radiation therapy of human sarcoma cells and tumors. Transl Oncol. 2013 Dec 01; 6(6):722-31. PMID: 24466375.
      View in: PubMed
    90. Wallner PE, Anscher MS, Barker CA, Bassetti M, Bristow RG, Cha YI, Dicker AP, Formenti SC, Graves EE, Hahn SM, Hei TK, Kimmelman AC, Kirsch DG, Kozak KR, Lawrence TS, Marples B, McBride WH, Mikkelsen RB, Park CC, Weidhaas JB, Zietman AL, Steinberg M. Current status and recommendations for the future of research, teaching, and testing in the biological sciences of radiation oncology: report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, executive summary. Int J Radiat Oncol Biol Phys. 2014 Jan 01; 88(1):11-7. PMID: 24246724.
      View in: PubMed
    91. Alonso-Basanta M, Fang P, Maity A, Hahn SM, Lustig RA, Dorsey JF. A phase I study of nelfinavir concurrent with temozolomide and radiotherapy in patients with glioblastoma multiforme. J Neurooncol. 2014 Jan; 116(2):365-372. PMID: 24194293.
      View in: PubMed
    92. Kusano AS, Thomas CR, Bonner JA, DeWeese TL, Formenti SC, Hahn SM, Lawrence TS, Mittal BB. Burnout in United States academic chairs of radiation oncology programs. Int J Radiat Oncol Biol Phys. 2014 Feb 01; 88(2):363-8. PMID: 24189126.
      View in: PubMed
    93. Simone CB, Hahn SM. What's in a Label? Radioimmunotherapy for metastatic prostate cancer. Clin Cancer Res. 2013 Sep 15; 19(18):4908-10. PMID: 23926229.
      View in: PubMed
    94. Dorsey JF, Sun L, Joh DY, Witztum A, Kao GD, Alonso-Basanta M, Avery S, Hahn SM, Al Zaki A, Tsourkas A. Gold nanoparticles in radiation research: potential applications for imaging and radiosensitization. Transl Cancer Res. 2013 Aug 01; 2(4):280-291. PMID: 25429358.
      View in: PubMed
    95. Simone CB, Wildt B, Haas AR, Pope G, Rengan R, Hahn SM. Stereotactic body radiation therapy for lung cancer. Chest. 2013 Jun; 143(6):1784-1790. PMID: 23732589.
      View in: PubMed
    96. Shah A, Hahn SM, Stetson RL, Friedberg JS, Pechet TT, Sher DJ. Cost-effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. Cancer. 2013 Sep 01; 119(17):3123-32. PMID: 23720093.
      View in: PubMed
    97. Gray PJ, Paly JJ, Yeap BY, Sanda MG, Sandler HM, Michalski JM, Talcott JA, Coen JJ, Hamstra DA, Shipley WU, Hahn SM, Zietman AL, Bekelman JE, Efstathiou JA. Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer. Cancer. 2013 May 01; 119(9):1729-35. PMID: 23436283.
      View in: PubMed
    98. Bekelman JE, Hahn SM. The body of evidence for advanced technology in radiation oncology. J Natl Cancer Inst. 2013 Jan 02; 105(1):6-7. PMID: 23243200.
      View in: PubMed
    99. Lin A, Hahn SM. Hypoxia imaging markers and applications for radiation treatment planning. Semin Nucl Med. 2012 Sep; 42(5):343-52. PMID: 22840599.
      View in: PubMed
    100. Lin LL, Silvoniemi A, Stubbs JB, Rengan R, Suilamo S, Solin O, Divgi C, Eskola O, Sorger JM, Stabin MG, Kachur A, Hahn SM, Grönroos TJ, Forsback S, Evans SM, Koch CJ, Minn H. Radiation dosimetry and biodistribution of the hypoxia tracer (18)F-EF5 in oncologic patients. Cancer Biother Radiopharm. 2012 Sep; 27(7):412-9. PMID: 22897720.
      View in: PubMed
    101. Friedberg JS, Culligan MJ, Mick R, Stevenson J, Hahn SM, Sterman D, Punekar S, Glatstein E, Cengel K. Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma. Ann Thorac Surg. 2012 May; 93(5):1658-65; discussion 1665-7. PMID: 22541196.
      View in: PubMed
    102. Rengan R, Mick R, Pryma D, Rosen MA, Lin LL, Maity AM, Evans TL, Stevenson JP, Langer CJ, Kucharczuk J, Friedberg J, Prendergast S, Sharkoski T, Hahn SM. A phase I trial of the HIV protease inhibitor nelfinavir with concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small cell lung cancer: a report of toxicities and clinical response. J Thorac Oncol. 2012 Apr; 7(4):709-15. PMID: 22425919.
      View in: PubMed
    103. Jagsi R, Bekelman JE, Brawley OW, Deasy JO, Le QT, Michalski JM, Movsas B, Thomas CR, Lawton CA, Lawrence TS, Hahn SM. A research agenda for radiation oncology: results of the radiation oncology institute's comprehensive research needs assessment. Int J Radiat Oncol Biol Phys. 2012 Oct 01; 84(2):318-22. PMID: 22436790.
      View in: PubMed
    104. Shah A, Efstathiou JA, Paly JJ, Halpern SD, Bruner DW, Christodouleas JP, Coen JJ, Deville C, Vapiwala N, Shipley WU, Zietman AL, Hahn SM, Bekelman JE. Prospective preference assessment of patients' willingness to participate in a randomized controlled trial of intensity-modulated radiotherapy versus proton therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2012 May 01; 83(1):e13-9. PMID: 22381899.
      View in: PubMed
    105. Zhu TC, Liang X, Sandell J, Finlay JC, Dimofte A, Rodriguez C, Cengel K, Friedberg J, Hahn SM, Glatstein E. A real-time treatment guidance system for Pleural PDT. Proc SPIE Int Soc Opt Eng. 2012 Feb 13; 8210. PMID: 26005245.
      View in: PubMed
    106. Simone CB, Friedberg JS, Glatstein E, Stevenson JP, Sterman DH, Hahn SM, Cengel KA. Photodynamic therapy for the treatment of non-small cell lung cancer. J Thorac Dis. 2012 Feb; 4(1):63-75. PMID: 22295169.
      View in: PubMed
    107. Worni M, Akushevich I, Gloor B, Scarborough J, Chino JP, Jacobs DO, Hahn SM, Clary BM, Pietrobon R, Shah A. Adjuvant radiotherapy in the treatment of invasive intraductal papillary mucinous neoplasm of the pancreas: an analysis of the surveillance, epidemiology, and end results registry. Ann Surg Oncol. 2012 Apr; 19(4):1316-23. PMID: 22002799.
      View in: PubMed
    108. Tian X, Ye J, Alonso-Basanta M, Hahn SM, Koumenis C, Dorsey JF. Modulation of CCAAT/enhancer binding protein homologous protein (CHOP)-dependent DR5 expression by nelfinavir sensitizes glioblastoma multiforme cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J Biol Chem. 2011 Aug 19; 286(33):29408-16. PMID: 21697087.
      View in: PubMed
    109. Friedberg JS, Mick R, Culligan M, Stevenson J, Fernandes A, Smith D, Glatstein E, Hahn SM, Cengel K. Photodynamic therapy and the evolution of a lung-sparing surgical treatment for mesothelioma. Ann Thorac Surg. 2011 Jun; 91(6):1738-45. PMID: 21619970.
      View in: PubMed
    110. Rengan R, Maity AM, Stevenson JP, Hahn SM. New strategies in non-small cell lung cancer: improving outcomes in chemoradiotherapy for locally advanced disease. Clin Cancer Res. 2011 Jul 01; 17(13):4192-9. PMID: 21576083.
      View in: PubMed
    111. Alonso-Basanta M, Chapman C, Dorsey JF, Rengan R, Hahn SM. A glimpse of the future: where will new combinations of diagnostics and therapies take us? Cancer J. 2011 May-Jun; 17(3):190-4. PMID: 21610473.
      View in: PubMed
    112. Christodouleas JP, Forrest RD, Ainsley CG, Tochner Z, Hahn SM, Glatstein E. Short-term and long-term health risks of nuclear-power-plant accidents. N Engl J Med. 2011 Jun 16; 364(24):2334-41. PMID: 21506737.
      View in: PubMed
    113. Bekelman JE, Shah A, Hahn SM. Implications of comparative effectiveness research for radiation oncology. Pract Radiat Oncol. 2011 Apr-Jun; 1(2):72-80. PMID: 24673918.
      View in: PubMed
    114. Zhu TC, Liang X, Chang C, Sandell J, Finlay JC, Dimofte A, Rodrigeus C, Cengel K, Friedberg J, Glatstein E, Hahn SM. An IR navigation system for real-time treatment guidance of Pleural PDT. Proc SPIE Int Soc Opt Eng. 2011 Feb 28; 7886. PMID: 26005244.
      View in: PubMed
    115. Berman AT, Litzky L, Livolsi V, Singhal S, Kucharczuk JC, Cooper JD, Friedberg JR, Evans TL, Stevenson JP, Metz JM, Hahn SM, Rengan R. Adjuvant radiotherapy for completely resected stage 2 thymoma. Cancer. 2011 Aug 01; 117(15):3502-8. PMID: 21287527.
      View in: PubMed
    116. Du KL, Both S, Friedberg JS, Rengan R, Hahn SM, Cengel KA. Extrapleural pneumonectomy, photodynamic therapy and intensity modulated radiation therapy for the treatment of malignant pleural mesothelioma. Cancer Biol Ther. 2010 Sep 01; 10(5):425-9. PMID: 20699634.
      View in: PubMed
    117. Rengan R, Hahn SM. Introduction: non-small-cell lung cancer and pleural malignancies: the end of the era of therapeutic nihilism? Semin Radiat Oncol. 2010 Jul; 20(3):147-8. PMID: 20685576.
      View in: PubMed
    118. Koch CJ, Scheuermann JS, Divgi C, Judy KD, Kachur AV, Freifelder R, Reddin JS, Karp J, Stubbs JB, Hahn SM, Driesbaugh J, Smith D, Prendergast S, Evans SM. Biodistribution and dosimetry of (18)F-EF5 in cancer patients with preliminary comparison of (18)F-EF5 uptake versus EF5 binding in human glioblastoma. Eur J Nucl Med Mol Imaging. 2010 Nov; 37(11):2048-59. PMID: 20585774.
      View in: PubMed
    119. Evans SM, Jenkins KW, Chen HI, Jenkins WT, Judy KD, Hwang WT, Lustig RA, Judkins AR, Grady MS, Hahn SM, Koch CJ. The Relationship among Hypoxia, Proliferation, and Outcome in Patients with De Novo Glioblastoma: A Pilot Study. Transl Oncol. 2010 Jun 01; 3(3):160-9. PMID: 20563257.
      View in: PubMed
    120. Wang KK, Finlay JC, Busch TM, Hahn SM, Zhu TC. Explicit dosimetry for photodynamic therapy: macroscopic singlet oxygen modeling. J Biophotonics. 2010 Jun; 3(5-6):304-18. PMID: 20222102.
      View in: PubMed
    121. Fernandes AT, Shen J, Finlay J, Mitra N, Evans T, Stevenson J, Langer C, Lin L, Hahn S, Glatstein E, Rengan R. Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes. Radiother Oncol. 2010 May; 95(2):178-84. PMID: 20356642.
      View in: PubMed
    122. Dimofte A, Zhu TC, Finlay JC, Cullighan M, Edmonds CE, Friedberg JS, Cengel K, Hahn SM. In-vivo light dosimetry for HPPH-mediated pleural PDT. Proc SPIE Int Soc Opt Eng. 2010 Mar 04; 7551. PMID: 26005243.
      View in: PubMed
    123. Finlay JC, Sandell JL, Zhu TC, Lewis R, Cengel KA, Hahn SM. Spectroscopic evaluation of photodynamic therapy of the intraperitoneal cavity. Proc SPIE Int Soc Opt Eng. 2010 Jan 23; 7551. PMID: 26028798.
      View in: PubMed
    124. Allegra CJ, Aberle DR, Ganschow P, Hahn SM, Lee CN, Millon-Underwood S, Pike MC, Reed SD, Saftlas AF, Scarvalone SA, Schwartz AM, Slomski C, Yothers G, Zon R. National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009. J Natl Cancer Inst. 2010 Feb 03; 102(3):161-9. PMID: 20071686.
      View in: PubMed
    125. Zhu TC, Altschuler MD, Hu Y, Wang K, Finlay JC, Dimofte A, Cengel K, Hahn SM. A heterogeneous optimization algorithm for reacted singlet oxygen for interstitial PDT. Proc SPIE Int Soc Opt Eng. 2010 Jan; 7551. PMID: 25995533.
      View in: PubMed
    126. Hill-Kayser CE, Avery S, Mesina CF, James P, Friedberg JS, Cengel K, Lin LL, Hahn SM, Rengan R. Hemithoracic radiotherapy after extrapleural pneumonectomy for malignant pleural mesothelioma: a dosimetric comparison of two well-described techniques. J Thorac Oncol. 2009 Nov; 4(11):1431-7. PMID: 19745767.
      View in: PubMed
    127. Cerniglia GJ, Pore N, Tsai JH, Schultz S, Mick R, Choe R, Xing X, Durduran T, Yodh AG, Evans SM, Koch CJ, Hahn SM, Quon H, Sehgal CM, Lee WM, Maity A. Epidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacy. PLoS One. 2009 Aug 06; 4(8):e6539. PMID: 19657384.
      View in: PubMed
    128. Lin LL, Hahn SM. Combined modality therapy in the elderly population. Curr Treat Options Oncol. 2009 Aug; 10(3-4):195-204. PMID: 19507038.
      View in: PubMed
    129. Lin A, Hahn SM. Photodynamic therapy: a light in the darkness? Clin Cancer Res. 2009 Jul 01; 15(13):4252-3. PMID: 19509131.
      View in: PubMed
    130. Hahn SM, Maity A. General principles of radiation and chemoradiation. Retina. 2009 Jun; 29(6 Suppl):S30-1. PMID: 19553795.
      View in: PubMed
    131. Altschuler MD, Zhu TC, Hu Y, Finlay JC, Dimofte A, Wang K, Li J, Cengel K, Malkowicz SB, Hahn SM. A heterogeneous algorithm for PDT dose optimization for prostate. Proc SPIE Int Soc Opt Eng. 2009 Feb 18; 7164:71640B. PMID: 25914793.
      View in: PubMed
    132. Dimofte A, Zhu TC, Finlay JC, Cullighan M, Edmonds CE, Friedberg JS, Cengel K, Hahn SM. In-vivo Light dosimetry for pleural PDT. Proc SPIE Int Soc Opt Eng. 2009 Jan 24; 7164. PMID: 25914792.
      View in: PubMed
    133. Evans SM, Jenkins KW, Jenkins WT, Dilling T, Judy KD, Schrlau A, Judkins A, Hahn SM, Koch CJ. Imaging and analytical methods as applied to the evaluation of vasculature and hypoxia in human brain tumors. Radiat Res. 2008 Dec; 170(6):677-90. PMID: 19138031.
      View in: PubMed
    134. Rengan R, Cengel KA, Hahn SM. Clinical target promiscuity: lessons from ras molecular trials. Cancer Metastasis Rev. 2008 Sep; 27(3):403-14. PMID: 18461427.
      View in: PubMed
    135. Patel H, Mick R, Finlay J, Zhu TC, Rickter E, Cengel KA, Malkowicz SB, Hahn SM, Busch TM. Motexafin lutetium-photodynamic therapy of prostate cancer: short- and long-term effects on prostate-specific antigen. Clin Cancer Res. 2008 Aug 01; 14(15):4869-76. PMID: 18676760.
      View in: PubMed
    136. Li J, Altschuler MD, Hahn SM, Zhu TC. Optimization of light source parameters in the photodynamic therapy of heterogeneous prostate. Phys Med Biol. 2008 Aug 07; 53(15):4107-21. PMID: 18612172.
      View in: PubMed
    137. Glatstein E, Glick J, Kaiser L, Hahn SM. Should randomized clinical trials be required for proton radiotherapy? An alternative view. J Clin Oncol. 2008 May 20; 26(15):2438-9. PMID: 18443345.
      View in: PubMed
    138. Evans SM, Du KL, Chalian AA, Mick R, Zhang PJ, Hahn SM, Quon H, Lustig R, Weinstein GS, Koch CJ. Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome. Int J Radiat Oncol Biol Phys. 2007 Nov 15; 69(4):1024-31. PMID: 17967299.
      View in: PubMed
    139. Lawton CA, DeSilvio M, Roach M, Uhl V, Kirsch R, Seider M, Rotman M, Jones C, Asbell S, Valicenti R, Hahn S, Thomas CR. An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions. Int J Radiat Oncol Biol Phys. 2007 Nov 01; 69(3):646-55. PMID: 17531401.
      View in: PubMed
    140. Jiang Z, Pore N, Cerniglia GJ, Mick R, Georgescu MM, Bernhard EJ, Hahn SM, Gupta AK, Maity A. Phosphatase and tensin homologue deficiency in glioblastoma confers resistance to radiation and temozolomide that is reversed by the protease inhibitor nelfinavir. Cancer Res. 2007 May 01; 67(9):4467-73. PMID: 17483362.
      View in: PubMed
    141. Gupta AK, Li B, Cerniglia GJ, Ahmed MS, Hahn SM, Maity A. The HIV protease inhibitor nelfinavir downregulates Akt phosphorylation by inhibiting proteasomal activity and inducing the unfolded protein response. Neoplasia. 2007 Apr; 9(4):271-8. PMID: 17460771.
      View in: PubMed
    142. Finlay JC, Zhu TC, Zhou X, Dimofte A, Malkowicz SB, Hahn SM. A method to improve reconstruction of the distribution of hemoglobin, oxygenation, and MLu concentration in the human prostate before and after photodynamic therapy. Proc SPIE Int Soc Opt Eng. 2007 Feb 27; 6427:64270K. PMID: 26136614.
      View in: PubMed
    143. Cengel KA, Glatstein E, Hahn SM. Intraperitoneal photodynamic therapy. Cancer Treat Res. 2007; 134:493-514. PMID: 17633077.
      View in: PubMed
    144. Pore N, Gupta AK, Cerniglia GJ, Jiang Z, Bernhard EJ, Evans SM, Koch CJ, Hahn SM, Maity A. Nelfinavir down-regulates hypoxia-inducible factor 1alpha and VEGF expression and increases tumor oxygenation: implications for radiotherapy. Cancer Res. 2006 Sep 15; 66(18):9252-9. PMID: 16982770.
      View in: PubMed
    145. Hahn SM, Putt ME, Metz J, Shin DB, Rickter E, Menon C, Smith D, Glatstein E, Fraker DL, Busch TM. Photofrin uptake in the tumor and normal tissues of patients receiving intraperitoneal photodynamic therapy. Clin Cancer Res. 2006 Sep 15; 12(18):5464-70. PMID: 17000681.
      View in: PubMed
    146. Finlay JC, Zhu TC, Dimofte A, Stripp D, Malkowicz SB, Busch TM, Hahn SM. Interstitial fluorescence spectroscopy in the human prostate during motexafin lutetium-mediated photodynamic therapy. Photochem Photobiol. 2006 Sep-Oct; 82(5):1270-8. PMID: 16808592.
      View in: PubMed
    147. Du KL, Mick R, Busch TM, Zhu TC, Finlay JC, Yu G, Yodh AG, Malkowicz SB, Smith D, Whittington R, Stripp D, Hahn SM. Preliminary results of interstitial motexafin lutetium-mediated PDT for prostate cancer. Lasers Surg Med. 2006 Jun; 38(5):427-34. PMID: 16788929.
      View in: PubMed
    148. Hahn SM, Fraker DL, Mick R, Metz J, Busch TM, Smith D, Zhu T, Rodriguez C, Dimofte A, Spitz F, Putt M, Rubin SC, Menon C, Wang HW, Shin D, Yodh A, Glatstein E. A phase II trial of intraperitoneal photodynamic therapy for patients with peritoneal carcinomatosis and sarcomatosis. Clin Cancer Res. 2006 Apr 15; 12(8):2517-25. PMID: 16638861.
      View in: PubMed
    149. Evans SM, Fraker D, Hahn SM, Gleason K, Jenkins WT, Jenkins K, Hwang WT, Zhang P, Mick R, Koch CJ. EF5 binding and clinical outcome in human soft tissue sarcomas. Int J Radiat Oncol Biol Phys. 2006 Mar 01; 64(3):922-7. PMID: 16458778.
      View in: PubMed
    150. Finlay JC, Zhu TC, Dimofte A, Friedberg JS, Hahn SM. Diffuse reflectance spectra measured in vivo in human tissues during Photofrin-mediated pleural photodynamic therapy. Proc SPIE Int Soc Opt Eng. 2006 Jan 21; 6139. PMID: 26113757.
      View in: PubMed
    151. Zhu TC, Li J, Finlay JC, Dimofte A, Stripp D, Malkowicz BS, Hahn SM. In-vivo light dosimetry of interstitial PDT of human prostate. Proc SPIE Int Soc Opt Eng. 2006 Jan 21; 6139. PMID: 26113758.
      View in: PubMed
    152. Verigos K, Stripp DC, Mick R, Zhu TC, Whittington R, Smith D, Dimofte A, Finlay J, Busch TM, Tochner ZA, Malkowicz S, Glatstein E, Hahn SM. Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer. J Environ Pathol Toxicol Oncol. 2006; 25(1-2):373-87. PMID: 16566729.
      View in: PubMed
    153. Altschuler MD, Zhu TC, Li J, Hahn SM. Optimized interstitial PDT prostate treatment planning with the Cimmino feasibility algorithm. Med Phys. 2005 Dec; 32(12):3524-36. PMID: 16475751.
      View in: PubMed
    154. Cengel KA, Hahn SM, Glatstein E. C225 and PDT combination therapy for ovarian cancer: the play's the thing. J Natl Cancer Inst. 2005 Oct 19; 97(20):1488-9. PMID: 16234556.
      View in: PubMed
    155. Brunner TB, Cengel KA, Hahn SM, Wu J, Fraker DL, McKenna WG, Bernhard EJ. Pancreatic cancer cell radiation survival and prenyltransferase inhibition: the role of K-Ras. Cancer Res. 2005 Sep 15; 65(18):8433-41. PMID: 16166322.
      View in: PubMed
    156. Finlay JC, Zhu TC, Dimofte A, Stripp D, Malkowicz SB, Whittington R, Miles J, Glatstein E, Hahn SM. In vivo measurement of fluorescence emission in the human prostate during photodynamic therapy. Proc SPIE Int Soc Opt Eng. 2005 Apr 22; 5689:299-310. PMID: 26136613.
      View in: PubMed
    157. Altschuler MD, Zhu TC, Li J, Hahn SM. Optimization of light sources for prostate photodynamic therapy. Proc SPIE Int Soc Opt Eng. 2005 Apr 22; 5689:186-197. PMID: 26136612.
      View in: PubMed
    158. Busch TM, Hahn SM. Multidrug resistance in photodynamic therapy. Cancer Biol Ther. 2005 Feb; 4(2):195-6. PMID: 15738647.
      View in: PubMed
    159. Zhu TC, Dimofte A, Finlay JC, Glatstein E, Hahn SM. Detector Calibration factor for interstitial in-vivo light dosimetry using isotropic detectors with scattering tip. Proc SPIE Int Soc Opt Eng. 2005 Jan 22; 5689. PMID: 26113754.
      View in: PubMed
    160. Zhu TC, Dimofte A, Finlay JC, Stripp D, Busch T, Miles J, Whittington R, Malkowicz SB, Tochner Z, Glatstein E, Hahn SM. Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy. Photochem Photobiol. 2005 Jan-Feb; 81(1):96-105. PMID: 15535736.
      View in: PubMed
    161. Evans SM, Judy KD, Dunphy I, Jenkins WT, Hwang WT, Nelson PT, Lustig RA, Jenkins K, Magarelli DP, Hahn SM, Collins RA, Grady MS, Koch CJ. Hypoxia is important in the biology and aggression of human glial brain tumors. Clin Cancer Res. 2004 Dec 15; 10(24):8177-84. PMID: 15623592.
      View in: PubMed
    162. Zhu TC, Finlay JC, Hahn SM. Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy. J Photochem Photobiol B. 2005 Jun 01; 79(3):231-41. PMID: 15896650.
      View in: PubMed
    163. Brunner TB, Hahn SM, McKenna WG, Bernhard EJ. Radiation sensitization by inhibition of activated Ras. Strahlenther Onkol. 2004 Nov; 180(11):731-40. PMID: 15549191.
      View in: PubMed
    164. Metz JM, Smith D, Mick R, Lustig R, Mitchell J, Cherakuri M, Glatstein E, Hahn SM. A phase I study of topical Tempol for the prevention of alopecia induced by whole brain radiotherapy. Clin Cancer Res. 2004 Oct 01; 10(19):6411-7. PMID: 15475427.
      View in: PubMed
    165. Martin NE, Hahn SM. Interstitial photodynamic therapy for prostate cancer: a developing modality. Photodiagnosis Photodyn Ther. 2004 Sep; 1(2):123-36. PMID: 25048183.
      View in: PubMed
    166. Martin NE, Brunner TB, Kiel KD, DeLaney TF, Regine WF, Mohiuddin M, Rosato EF, Haller DG, Stevenson JP, Smith D, Pramanik B, Tepper J, Tanaka WK, Morrison B, Deutsch P, Gupta AK, Muschel RJ, McKenna WG, Bernhard EJ, Hahn SM. A phase I trial of the dual farnesyltransferase and geranylgeranyltransferase inhibitor L-778,123 and radiotherapy for locally advanced pancreatic cancer. Clin Cancer Res. 2004 Aug 15; 10(16):5447-54. PMID: 15328183.
      View in: PubMed
    167. Busch TM, Hahn SM, Wileyto EP, Koch CJ, Fraker DL, Zhang P, Putt M, Gleason K, Shin DB, Emanuele MJ, Jenkins K, Glatstein E, Evans SM. Hypoxia and Photofrin uptake in the intraperitoneal carcinomatosis and sarcomatosis of photodynamic therapy patients. Clin Cancer Res. 2004 Jul 15; 10(14):4630-8. PMID: 15269134.
      View in: PubMed
    168. Friedberg JS, Mick R, Stevenson JP, Zhu T, Busch TM, Shin D, Smith D, Culligan M, Dimofte A, Glatstein E, Hahn SM. Phase II trial of pleural photodynamic therapy and surgery for patients with non-small-cell lung cancer with pleural spread. J Clin Oncol. 2004 Jun 01; 22(11):2192-201. PMID: 15169808.
      View in: PubMed
    169. Wendt TG, Gademann G, Pambor C, Grießbach I, von Specht H, Martin T, Baltas D, Kurek R, Röddiger S, Tunn UW, Zamboglou N, Eich HT, Staar S, Gossmann A, Hansemann K, Semrau R, Skripnitchenko R, Diehl V, Müller RP, Sehlen S, Willich N, Rühl U, Lukas P, Dühmke E, Engel K, Tabbert E, Bolck M, Knaack S, Annweiler H, Krempien R, Hoppe H, Harms W, Daeuber S, Schorr O, Treiber M, Debus J, Alber M, Paulsen F, Birkner M, Bakai A, Belka C, Budach W, Grosser KH, Kramer R, Kober B, Reinert M, Schneider P, Hertel A, Feldmann H, Csere P, Hoinkis C, Rothe G, Zahn P, Alheit H, Cavanaugh SX, Kupelian P, Reddy C, Pollock B, Fuss M, Roeddiger S, Dannenberg T, Rogge B, Drechsler D, Herrmann T, Alberti W, Schwarz R, Graefen M, Krüll A, Rudat V, Huland H, Fehr C, Baum C, Glocker S, Nüsslin F, Heil T, Lemnitzer H, Knips M, Baumgart O, Thiem W, Kloetzer KH, Hoffmann L, Neu B, Hültenschmidt B, Sautter-Bihl ML, Micke O, Seegenschmiedt MH, Köppen D, Klautke G, Fietkau R, Schultze J, Schlichting G, Koltze H, Kimmig B, Glatzel M, Fröhlich D, Bäsecke S, Krauß A, Strauß D, Buth KJ, Böhme R, Oehler W, Bottke D, Keilholz U, Heufelder K, Wiegel T, Hinkelbein W, Rödel C, Papadopoulos T, Munnes M, Wirtz R, Sauer R, Rödel F, Lubgan D, Distel L, Grabenbauer GG, Sak A, Stüben G, Pöttgen C, Grehl S, Stuschke M, Müller K, Pfaffendorf C, Mayerhofer A, Köhn FM, Ring J, van Beuningen D, Meineke V, Neubauer S, Keller U, Wittlinger M, Riesenbeck D, Greve B, Exeler R, Ibrahim M, Liebscher C, Severin E, Ott O, Pötter R, Hammer J, Hildebrandt G, Beckmann MW, Strnad V, Fehlauer F, Tribius S, Bajrovic A, Höller U, Rades D, Warszawski A, Baumann R, Madry-Gevecke B, Karstens JH, Grehn C, Hensley F, Berns C, Wannenmacher M, Semrau S, Reimer T, Gerber B, Ketterer P, Koepcke E, Hänsgen G, Strauß HG, Dunst J, Füller J, Kalb S, Wendt T, Weitmann HD, Waldhäusl C, Knocke TH, Lamprecht U, Classen J, Kaulich TW, Aydeniz B, Bamberg M, Wiezorek T, Banz N, Salz H, Scheithauer M, Schwedas M, Lutterbach J, Bartelt S, Frommhold H, Lambert J, Hornung D, Swiderski S, Walke M, Siefert A, Pöllinger B, Krimmel K, Schaffer M, Koelbl O, Bratengeier K, Vordermark D, Flentje M, Hero B, Berthold F, Combs SE, Gutwein S, Schulz-Ertner D, van Kampen M, Thilmann C, Kocher M, Kunze S, Schild S, Ikezaki K, Müller B, Sieber R, Weiß C, Wolf I, Wenz F, Weber KJ, Schäfer J, Engling A, Laufs S, Veldwijk MR, Milanovic D, Fleckenstein K, Zeller W, Fruehauf S, Herskind C, Weinmann M, Jendrossek V, Rübe C, Appold S, Kusche S, Hölscher T, Brüchner K, Geyer P, Baumann M, Kumpf R, Zimmermann F, Schill S, Geinitz H, Nieder C, Jeremic B, Molls M, Liesenfeld S, Petrat H, Hesselmann S, Schäfer U, Bruns F, Horst E, Wilkowski R, Assmann G, Nolte A, Diebold J, Löhrs U, Fritz P, Hans-Jürgen K, Mühlnickel W, Bach P, Wahlers B, Kraus HJ, Wulf J, Hädinger U, Baier K, Krieger T, Müller G, Hof H, Herfarth K, Brunner T, Hahn SM, Schreiber FS, Rustgi AK, McKenna WG, Bernhard EJ, Guckenberger M, Meyer K, Willner J, Schmidt M, Kolb M, Li M, Gong P, Abdollahi A, Trinh T, Huber PE, Christiansen H, Saile B, Neubauer-Saile K, Tippelt S, Rave-Fränk M, Hermann RM, Dudas J, Hess CF, Schmidberger H, Ramadori G, Andratschke N, Price R, Ang KK, Schwarz S, Kulka U, Busch M, Schlenger L, Bohsung J, Eichwurzel I, Matnjani G, Sandrock D, Richter M, Wurm R, Budach V, Feussner A, Gellermann J, Jordan A, Scholz R, Gneveckow U, Maier-Hauff K, Ullrich R, Wust P, Felix R, Waldöfner N, Seebass M, Ochel HJ, Dani A, Varkonyi A, Osvath M, Szasz A, Messer PM, Blumstein NM, Gottfried HW, Schneider E, Reske SN, Röttinger EM, Grosu AL, Franz M, Stärk S, Weber W, Heintz M, Indenkämpen F, Beyer T, Lübcke W, Levegrün S, Hayen J, Czech N, Mbarek B, Köster R, Thurmann H, Todorovic M, Schuchert A, Meinertz T, Münzel T, Grundtke H, Hornig B, Hehr T, Dilcher C, Chan RC, Mintz GS, Kotani JI, Shah VM, Canos DA, Weissman NJ, Waksman R, Wolfram R, Bürger B, Schrappe M, Timmermann B, Lomax A, Goitein G, Schuck A, Mattke A, Int-Veen C, Brecht I, Bernhard S, Treuner J, et al. [Not Available]. Strahlenther Onkol. 2004 Jun; 180 Suppl 1:5-87. PMID: 27137922.
      View in: PubMed
    170. Wilson JJ, Jones H, Burock M, Smith D, Fraker DL, Metz J, Glatstein E, Hahn SM. Patterns of recurrence in patients treated with photodynamic therapy for intraperitoneal carcinomatosis and sarcomatosis. Int J Oncol. 2004 Mar; 24(3):711-7. PMID: 14767557.
      View in: PubMed
    171. Evans SM, Judy KD, Dunphy I, Jenkins WT, Nelson PT, Collins R, Wileyto EP, Jenkins K, Hahn SM, Stevens CW, Judkins AR, Phillips P, Geoerger B, Koch CJ. Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding. Cancer Res. 2004 Mar 01; 64(5):1886-92. PMID: 14996753.
      View in: PubMed
    172. Zhu TC, Finlay JC, Dimofte A, Hahn SM. Light Dosimetry at Tissue Surfaces for Oblique Incident Circular Fields. Proc SPIE Int Soc Opt Eng. 2004; 5315:113-124. PMID: 26139956.
      View in: PubMed
    173. Gupta AK, Soto DE, Feldman MD, Goldsmith JD, Mick R, Hahn SM, Machtay M, Muschel RJ, McKenna WG. Signaling pathways in NSCLC as a predictor of outcome and response to therapy. Lung. 2004; 182(3):151-62. PMID: 15526754.
      View in: PubMed
    174. Brunner TB, Hahn SM, Gupta AK, Muschel RJ, McKenna WG, Bernhard EJ. Farnesyltransferase inhibitors: an overview of the results of preclinical and clinical investigations. Cancer Res. 2003 Sep 15; 63(18):5656-68. PMID: 14522880.
      View in: PubMed
    175. McKenna WG, Muschel RJ, Gupta AK, Hahn SM, Bernhard EJ. The RAS signal transduction pathway and its role in radiation sensitivity. Oncogene. 2003 Sep 01; 22(37):5866-75. PMID: 12947393.
      View in: PubMed
    176. Yom SS, Busch TM, Friedberg JS, Wileyto EP, Smith D, Glatstein E, Hahn SM. Elevated serum cytokine levels in mesothelioma patients who have undergone pleurectomy or extrapleural pneumonectomy and adjuvant intraoperative photodynamic therapy. Photochem Photobiol. 2003 Jul; 78(1):75-81. PMID: 12929752.
      View in: PubMed
    177. Brunner TB, Gupta AK, Shi Y, Hahn SM, Muschel RJ, McKenna WG, Bernhard EJ. Farnesyltransferase inhibitors as radiation sensitizers. Int J Radiat Biol. 2003 Jul; 79(7):569-76. PMID: 14530152.
      View in: PubMed
    178. De Graff WG, Myers LS, Mitchell JB, Hahn SM. Protection against Adriamycin cytotoxicity and inhibition of DNA topoisomerase II activity by 3,4-dihydroxybenzoic acid. Int J Oncol. 2003 Jul; 23(1):159-63. PMID: 12792789.
      View in: PubMed
    179. Flaherty KT, Stevenson JP, Hahn SM, Redlinger M, O'Dwyer PJ. Phase I combination trial of gemcitabine, paclitaxel, and carboplatin in patients with advanced malignancy. Cancer Chemother Pharmacol. 2003 Sep; 52(3):217-22. PMID: 12811513.
      View in: PubMed
    180. Zhu TC, Dimofte A, Hahn SM, Lustig RA. Light Dosimetry at Tissue Surfaces for Small Circular Fields. Proc SPIE Int Soc Opt Eng. 2003 Jun 12; 4952:56-67. PMID: 26146441.
      View in: PubMed
    181. McKenna WG, Muschel RJ, Gupta A, Hahn S, Bernhard EJ. Signaling inhibition with radiation in colorectal cancer: clinical trials. Semin Oncol. 2003 Jun; 30(3 Suppl 6):56-67. PMID: 12802796.
      View in: PubMed
    182. Canter RJ, Mick R, Kesmodel SB, Raz DJ, Spitz FR, Metz JM, Glatstein EJ, Hahn SM, Fraker DL. Intraperitoneal photodynamic therapy causes a capillary-leak syndrome. Ann Surg Oncol. 2003 Jun; 10(5):514-24. PMID: 12794017.
      View in: PubMed
    183. Colevas AD, Brown JM, Hahn S, Mitchell J, Camphausen K, Coleman CN. Development of investigational radiation modifiers. J Natl Cancer Inst. 2003 May 07; 95(9):646-51. PMID: 12734315.
      View in: PubMed
    184. Cheung R, Solonenko M, Busch TM, Del Piero F, Putt ME, Hahn SM, Yodh AG. Correlation of in vivo photosensitizer fluorescence and photodynamic-therapy-induced depth of necrosis in a murine tumor model. J Biomed Opt. 2003 Apr; 8(2):248-52. PMID: 12683850.
      View in: PubMed
    185. Friedberg JS, Mick R, Stevenson J, Metz J, Zhu T, Buyske J, Sterman DH, Pass HI, Glatstein E, Hahn SM. A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma. Ann Thorac Surg. 2003 Mar; 75(3):952-9. PMID: 12645723.
      View in: PubMed
    186. Mitchell JB, Xavier S, DeLuca AM, Sowers AL, Cook JA, Krishna MC, Hahn SM, Russo A. A low molecular weight antioxidant decreases weight and lowers tumor incidence. Free Radic Biol Med. 2003 Jan 01; 34(1):93-102. PMID: 12498984.
      View in: PubMed
    187. Zhu TC, Hahn SM, Kapatkin AS, Dimofte A, Rodriguez CE, Vulcan TG, Glatstein E, Hsi RA. In vivo optical properties of normal canine prostate at 732 nm using motexafin lutetium-mediated photodynamic therapy. Photochem Photobiol. 2003 Jan; 77(1):81-8. PMID: 12856887.
      View in: PubMed
    188. Stevenson JP, Sun W, Gallagher M, Johnson R, Vaughn D, Schuchter L, Algazy K, Hahn S, Enas N, Ellis D, Thornton D, O'Dwyer PJ. Phase I trial of the cryptophycin analogue LY355703 administered as an intravenous infusion on a day 1 and 8 schedule every 21 days. Clin Cancer Res. 2002 Aug; 8(8):2524-9. PMID: 12171879.
      View in: PubMed
    189. McKenna WG, Muschel RJ, Gupta AK, Hahn SM, Bernhard EJ. Farnesyltransferase inhibitors as radiation sensitizers. Semin Radiat Oncol. 2002 Jul; 12(3 Suppl 2):27-32. PMID: 12174342.
      View in: PubMed
    190. Robnett TJ, Machtay M, Hahn SM, Shrager JB, Friedberg JS, Kaiser LR. Pathological response to preoperative chemoradiation worsens with anemia in non-small cell lung cancer patients. Cancer J. 2002 May-Jun; 8(3):263-7. PMID: 12074326.
      View in: PubMed
    191. Hahn SM, Bernhard EJ, Regine W, Mohiuddin M, Haller DG, Stevenson JP, Smith D, Pramanik B, Tepper J, DeLaney TF, Kiel KD, Morrison B, Deutsch P, Muschel RJ, McKenna WG. A Phase I trial of the farnesyltransferase inhibitor L-778,123 and radiotherapy for locally advanced lung and head and neck cancer. Clin Cancer Res. 2002 May; 8(5):1065-72. PMID: 12006520.
      View in: PubMed
    192. Solonenko M, Cheung R, Busch TM, Kachur A, Griffin GM, Vulcan T, Zhu TC, Wang HW, Hahn SM, Yodh AG. In vivo reflectance measurement of optical properties, blood oxygenation and motexafin lutetium uptake in canine large bowels, kidneys and prostates. Phys Med Biol. 2002 Mar 21; 47(6):857-73. PMID: 11936174.
      View in: PubMed
    193. Jones HA, Metz JM, Devine P, Hahn SM, Whittington R. Rates of unconventional medical therapy use in patients with prostate cancer: standard history versus directed questions. Urology. 2002 Feb; 59(2):272-6. PMID: 11834401.
      View in: PubMed
    194. Dimofte A, Zhu TC, Hahn SM, Lustig RA. In vivo light dosimetry for motexafin lutetium-mediated PDT of recurrent breast cancer. Lasers Surg Med. 2002; 31(5):305-12. PMID: 12430147.
      View in: PubMed
    195. Menon C, Kutney SN, Lehr SC, Hendren SK, Busch TM, Hahn SM, Fraker DL. Vascularity and uptake of photosensitizer in small human tumor nodules: implications for intraperitoneal photodynamic therapy. Clin Cancer Res. 2001 Dec; 7(12):3904-11. PMID: 11751481.
      View in: PubMed
    196. Hahn SM, Bernhard E, McKenna WG. Farnesyltransferase inhibitors. Semin Oncol. 2001 Oct; 28(5 Suppl 16):86-93. PMID: 11706400.
      View in: PubMed
    197. Hahn SM, Smith RP, Friedberg J. Photodynamic therapy for mesothelioma. Curr Treat Options Oncol. 2001 Oct; 2(5):375-83. PMID: 12057100.
      View in: PubMed
    198. Jones HA, Hahn SM, Bernhard E, McKenna WG. Ras inhibitors and radiation therapy. Semin Radiat Oncol. 2001 Oct; 11(4):328-37. PMID: 11677657.
      View in: PubMed
    199. Evans SM, Hahn SM, Magarelli DP, Koch CJ. Hypoxic heterogeneity in human tumors: EF5 binding, vasculature, necrosis, and proliferation. Am J Clin Oncol. 2001 Oct; 24(5):467-72. PMID: 11586098.
      View in: PubMed
    200. Koch CJ, Hahn SM, Rockwell K, Covey JM, McKenna WG, Evans SM. Pharmacokinetics of EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitroimidazoles. Cancer Chemother Pharmacol. 2001 Sep; 48(3):177-87. PMID: 11592338.
      View in: PubMed
    201. Bauer TW, Hahn SM, Spitz FR, Kachur A, Glatstein E, Fraker DL. Preliminary report of photodynamic therapy for intraperitoneal sarcomatosis. Ann Surg Oncol. 2001 Apr; 8(3):254-9. PMID: 11314943.
      View in: PubMed
    202. Robnett TJ, Machtay M, Stevenson JP, Algazy KM, Hahn SM. Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma. J Clin Oncol. 2001 Mar 01; 19(5):1344-9. PMID: 11230477.
      View in: PubMed
    203. Griffin GM, Zhu T, Solonenko M, Del Piero F, Kapakin A, Busch TM, Yodh A, Polin G, Bauer T, Fraker D, Hahn SM. Preclinical evaluation of motexafin lutetium-mediated intraperitoneal photodynamic therapy in a canine model. Clin Cancer Res. 2001 Feb; 7(2):374-81. PMID: 11234893.
      View in: PubMed
    204. Evans SM, Hahn SM, Magarelli DP, Zhang PJ, Jenkins WT, Fraker DL, Hsi RA, McKenna WG, Koch CJ. Hypoxia in human intraperitoneal and extremity sarcomas. Int J Radiat Oncol Biol Phys. 2001 Feb 01; 49(2):587-96. PMID: 11173159.
      View in: PubMed
    205. Sanfilippo NJ, Hsi A, DeNittis AS, Ginsberg GG, Kochman ML, Friedberg JS, Hahn SM. Toxicity of photodynamic therapy after combined external beam radiotherapy and intraluminal brachytherapy for carcinoma of the upper aerodigestive tract. Lasers Surg Med. 2001; 28(3):278-81. PMID: 11295765.
      View in: PubMed
    206. Hsiung-Stripp DC, McDonough J, Masters HM, Levin WP, Hahn SM, Jones HA, Metz JM. Comparative treatment planning between proton and X-ray therapy in pancreatic cancer. Med Dosim. 2001; 26(3):255-9. PMID: 11704461.
      View in: PubMed
    207. Hendren SK, Hahn SM, Spitz FR, Bauer TW, Rubin SC, Zhu T, Glatstein E, Fraker DL. Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Ann Surg Oncol. 2001 Jan-Feb; 8(1):65-71. PMID: 11206227.
      View in: PubMed
    208. Busch TM, Hahn SM, Evans SM, Koch CJ. Depletion of tumor oxygenation during photodynamic therapy: detection by the hypoxia marker EF3 [2-(2-nitroimidazol-1[H]-yl)-N-(3,3,3-trifluoropropyl)acetamide ]. Cancer Res. 2000 May 15; 60(10):2636-42. PMID: 10825135.
      View in: PubMed
    209. Evans SM, Hahn S, Pook DR, Jenkins WT, Chalian AA, Zhang P, Stevens C, Weber R, Weinstein G, Benjamin I, Mirza N, Morgan M, Rubin S, McKenna WG, Lord EM, Koch CJ. Detection of hypoxia in human squamous cell carcinoma by EF5 binding. Cancer Res. 2000 Apr 01; 60(7):2018-24. PMID: 10766193.
      View in: PubMed
    210. Hahn SM, Krishna MC, DeLuca AM, Coffin D, Mitchell JB. Evaluation of the hydroxylamine Tempol-H as an in vivo radioprotector. Free Radic Biol Med. 2000 Mar 15; 28(6):953-8. PMID: 10802227.
      View in: PubMed
    211. Lee JH, Machtay M, Kaiser LR, Friedberg JS, Hahn SM, McKenna MG, McKenna WG. Non-small cell lung cancer: prognostic factors in patients treated with surgery and postoperative radiation therapy. Radiology. 1999 Dec; 213(3):845-52. PMID: 10580965.
      View in: PubMed
    212. Hahn SM, Sullivan FJ, DeLuca AM, Bacher JD, Liebmann J, Krishna MC, Coffin D, Mitchell JB. Hemodynamic effect of the nitroxide superoxide dismutase mimics. Free Radic Biol Med. 1999 Sep; 27(5-6):529-35. PMID: 10490272.
      View in: PubMed
    213. Engbrecht BW, Menon C, Kachur AV, Hahn SM, Fraker DL. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model. Cancer Res. 1999 Sep 01; 59(17):4334-42. PMID: 10485481.
      View in: PubMed
    214. Hahn SM, Russo A, Cook JA, Mitchell JB. A multidrug-resistant breast cancer cell line induced by weekly exposure to doxorubicin. Int J Oncol. 1999 Feb; 14(2):273-9. PMID: 9917502.
      View in: PubMed
    215. Hahn SM, DeLuca AM, Coffin D, Krishna CM, Mitchell JB. In vivo radioprotection and effects on blood pressure of the stable free radical nitroxides. Int J Radiat Oncol Biol Phys. 1998 Nov 01; 42(4):839-42. PMID: 9845107.
      View in: PubMed
    216. Kuppusamy P, Afeworki M, Shankar RA, Coffin D, Krishna MC, Hahn SM, Mitchell JB, Zweier JL. In vivo electron paramagnetic resonance imaging of tumor heterogeneity and oxygenation in a murine model. Cancer Res. 1998 Apr 01; 58(7):1562-8. PMID: 9537265.
      View in: PubMed
    217. Herscher LL, Hahn SM, Kroog G, Pass H, Temeck B, Goldspiel B, Cook J, Mitchell JB, Liebmann J. Phase I study of paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small-cell lung cancer. J Clin Oncol. 1998 Feb; 16(2):635-41. PMID: 9469352.
      View in: PubMed
    218. Hahn SM, Sullivan FJ, DeLuca AM, Krishna CM, Wersto N, Venzon D, Russo A, Mitchell JB. Evaluation of tempol radioprotection in a murine tumor model. Free Radic Biol Med. 1997; 22(7):1211-6. PMID: 9098095.
      View in: PubMed
    219. Hahn SM, Mitchell JB, Shacter E. Tempol inhibits neutrophil and hydrogen peroxide-mediated DNA damage. Free Radic Biol Med. 1997; 23(6):879-84. PMID: 9378367.
      View in: PubMed
    220. Hahn SM, Lepinski DL, DeLuca AM, Mitchell JB, Pellmar TC. Neurophysiological consequences of nitroxide antioxidants. Can J Physiol Pharmacol. 1995 Mar; 73(3):399-403. PMID: 7648519.
      View in: PubMed
    221. DeGraff W, Hahn SM, Mitchell JB, Krishna MC. Free radical modes of cytotoxicity of adriamycin and streptonigrin. Biochem Pharmacol. 1994 Oct 07; 48(7):1427-35. PMID: 7945443.
      View in: PubMed
    222. Hahn SM, Krishna CM, Samuni A, DeGraff W, Cuscela DO, Johnstone P, Mitchell JB. Potential use of nitroxides in radiation oncology. Cancer Res. 1994 Apr 01; 54(7 Suppl):2006s-2010s. PMID: 8137329.
      View in: PubMed
    223. Hahn SM, Krishna CM, Mitchell JB. New directions for free radical cancer research and medical applications. Adv Exp Med Biol. 1994; 366:241-51. PMID: 7771256.
      View in: PubMed
    224. Hahn SM, Liebmann JE, Cook J, Fisher J, Goldspiel B, Venzon D, Mitchell JB, Kaufman D. Taxol in combination with doxorubicin or etoposide. Possible antagonism in vitro. Cancer. 1993 Nov 01; 72(9):2705-11. PMID: 8104682.
      View in: PubMed
    225. Liebmann JE, Hahn SM, Cook JA, Lipschultz C, Mitchell JB, Kaufman DC. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity. Cancer Res. 1993 May 01; 53(9):2066-70. PMID: 8097674.
      View in: PubMed
    226. Hahn SM, Wilson L, Krishna CM, Liebmann J, DeGraff W, Gamson J, Samuni A, Venzon D, Mitchell JB. Identification of nitroxide radioprotectors. Radiat Res. 1992 Oct; 132(1):87-93. PMID: 1410280.
      View in: PubMed
    227. Pogrebniak HW, Merino MJ, Hahn SM, Mitchell JB, Pass HI. Spin trap salvage from endotoxemia: the role of cytokine down-regulation. Surgery. 1992 Aug; 112(2):130-9; discussion 138-9. PMID: 1641756.
      View in: PubMed
    228. Krishna CM, Liebmann JE, Kaufman D, DeGraff W, Hahn SM, McMurry T, Mitchell JB, Russo A. The catecholic metal sequestering agent 1,2-dihydroxybenzene-3,5-disulfonate confers protection against oxidative cell damage. Arch Biochem Biophys. 1992 Apr; 294(1):98-106. PMID: 1312813.
      View in: PubMed
    229. Hahn SM, Tochner Z, Krishna CM, Glass J, Wilson L, Samuni A, Sprague M, Venzon D, Glatstein E, Mitchell JB, et al. Tempol, a stable free radical, is a novel murine radiation protector. Cancer Res. 1992 Apr 01; 52(7):1750-3. PMID: 1551104.
      View in: PubMed
    230. Mitchell JB, DeGraff W, Kaufman D, Krishna MC, Samuni A, Finkelstein E, Ahn MS, Hahn SM, Gamson J, Russo A. Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic, tempol. Arch Biochem Biophys. 1991 Aug 15; 289(1):62-70. PMID: 1654848.
      View in: PubMed
    231. Hahn SM, Krishna CM, Samuni A, Mitchell JB, Russo A. Mn(III)-desferrioxamine superoxide dismutase-mimic: alternative modes of action. Arch Biochem Biophys. 1991 Jul; 288(1):215-9. PMID: 1654823.
      View in: PubMed
    232. Samuni A, Winkelsberg D, Pinson A, Hahn SM, Mitchell JB, Russo A. Nitroxide stable radicals protect beating cardiomyocytes against oxidative damage. J Clin Invest. 1991 May; 87(5):1526-30. PMID: 1850756.
      View in: PubMed
    233. Light Dosimetry at Tissue Surfaces for Small Circular Fields. 56-67.
    234. Diffuse reflectance spectra measured in vivo in human tissues during photofrin-mediated pleural photodynamic therapy.
    235. Immune Priming of the Tumor Microenvironment by Radiation. Trends in Cancer. 2:638-645.
    236. Detector Calibration factor for interstitial in-vivo light dosimetry using isotropic detectors with scattering tip. 174-185.
    237. Spectroscopic evaluation of photodynamic therapy of the intraperitoneal cavity.
    238. In vivo measurements of penetration depth, oxygenation, and drug concentration using broadband absorption spectroscopy in human tissues before and after photodynamic therapy. 68-75.
    239. A novel approach for the detection and genetic analysis of live melanoma circulating tumor cells. PLoS One. 10.
    240. A heterogeneous optimization algorithm for reacted singlet oxygen for interstitial PDT.
    241. Light dosimetry at tissue surfaces for oblique incident circular fields. 113-124.
    242. Diffuse reflectance spectra measured in vivo in human tissues during Photofrin-mediated pleural photodynamic therapy.
    243. In vivo determination of the lutetium texaphyrin concentration in canine using fluorescence technique. 775-777.
    244. Technology for Innovation in Radiation Oncology. International Journal of Radiation Oncology Biology Physics. 93:485-492.
    245. Theranostic gold nanoparticles modified for durable systemic circulation effectively and safely enhance the radiation therapy of human sarcoma cells and tumors. Translational Oncology. 6:722-731.
    246. Cervical cancer in Botswana. Frontiers in Oncology. 5.
    247. A method to improve reconstruction of the distribution of hemoglobin, oxygenation, and MLu concentration in the human prostate before and after photodynamic therapy.
    248. Treatment of mesothelioma with radiotherapy. 616-627.
    249. The implementation and assessment of a quality and safety culture education program in a large radiation oncology department. Practical Radiation Oncology.
    250. In-vivo Light dosimetry for pleural PDT.
    251. A real-time treatment guidance system for pleural PDT.
    252. Therapy for malignant pleural mesothelioma. 629-651.
    253. Phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer. 88-99.
    254. Journey toward high reliability. Journal of Oncology Practice. 12:e603-e612.
    255. Broadband reflectance measurements of light penetration, blood oxygenation, hemoglobin concentration, and drug concentration in human intraperitoneal tissues before and after photodynamic therapy. Journal of Biomedical Optics. 10.
    256. Intraperitoneal photodynamic therapy. 493-514.
    257. Optimization of light sources for prostate photodynamic therapy. 186-197.
    258. Extended Pleurectomy-Decortication-Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years. Annals of Thoracic Surgery.
    259. Proton pencil beam scanning for mediastinal lymphoma. Acta oncologica. 1-7.
    260. Comparison of depth dependence of light fluence rate in intralipid for wavelengths between 532-730 nm. 884-887.
    261. The International Cancer Expert Corps. Frontiers in Oncology. 4.
    262. Training global oncologists. Frontiers in Oncology. 5.
    263. Corrigendum to Training global oncologists. Frontiers in Oncology. 5.
    264. In vivo light dosimetry for HPPH-mediated pleural PDT.
    265. Clinical applications for photodynamic therapy in oncology. 10-27.
    266. Proton beam therapy. Postgraduate Medical Journal. 91:241-243.
    267. An IR navigation system for real-time treatment guidance of pleural PDT.
    268. Intraperitoneal photodynamic therapy for peritoneal carcinomatosis and sarcomatosis. 2-9.
    269. A heterogeneous algorithm for PDT dose optimization for prostate.
    270. The ratio of the spherical and flat detectors at tissue surfaces during pleural photodynamic therapy. 102-113.
    271. Diffuse optical measurements of tissue blood flow and oxygenation during interstitial prostate PDT.
    272. Two-dimensional/three dimensional hybrid interstitial diffuse optical tomography of human prostate during photodynamic therapy.
    273. Linked statistical shape models for multi-modal segmentation.
    274. Blood flow responses to photodynamic therapy with two photosensitizers.
    275. In vivo determination of the absorption and scattering spectra of the human prostate during photodynamic therapy. 132-142.
    276. An automated electronic system for managing radiation treatment plan peer review reduces missed reviews at a large, high-volume academic center. Practical Radiation Oncology.
    277. The emergence of photodynamic therapy as a major modality in cancer treatment. Reviews in Contemporary Pharmacotherapy. 10:69-74.
    278. Fluence rate variability among light delivery devices for esophageal photodynamic therapy.
    279. Society of chairs of academic radiation oncology programs-endorsed radiation oncology department review process. International Journal of Radiation Oncology Biology Physics. 92:536-539.
    280. Proton therapy for head and neck cancer. Translational Cancer Research. 1:255-263.
    281. Interstitial photodynamic therapy for prostate cancer. Photodiagnosis and Photodynamic Therapy. 1:123-136.
    282. Assessing the quality of a radiation oncology case-based peer-review program in an integrated academic and community cancer center network. Journal of Oncology Practice. 12:e476-e486.
    283. Supply and Demand for Radiation Oncology in the United States. International Journal of Radiation Oncology Biology Physics.
    284. Association of in-vivo and ex-vivo measurements of tissue oxygenation and photosensitizer concentration in patients with intraperitoneal caracinomatosis.
    285. Preclinical rationale and clinical considerations for radiotherapy plus immunotherapy going beyond local control. Cancer Journal (United States). 22:130-137.
    286. In vivo measurement of fluorescence emission in the human prostate during photodynamic therapy. 299-310.
    287. Implications of comparative effectiveness research for radiation oncology. Practical Radiation Oncology. 1:72-80.
    288. Proton therapy for head and neck cancer. Current Opinion in Oncology. 27:165-171.
    289. Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated Killing. International Journal of Radiation Oncology Biology Physics. 95:120-130.
    290. Therapeutic Approaches to Malignant Mesothelioma.
    291. Gold nanoparticles in radiation research. Translational Cancer Research. 2:280-291.
    292. Future developments in radiation oncology for the management of carcinoma of the lung. Lung Cancer. 9:81-87.
    293. In-vivo light dosimetry of interstitial PDT of human prostote.
    HAHN's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description